Lung Cancers Unknown Status Phase 2 Trials for Paclitaxel (DB01229)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01024712Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00616031Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00550537Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTreatment
NCT00465907Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung CancerTreatment
NCT00083083Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung CancerDiagnostic
NCT00006469Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung CancerTreatment
NCT00004253Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryTreatment
NCT00004265Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung CancerTreatment
NCT00003284High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung CancerTreatment